Gain of chromosome 7, which marks the progression from indolent to aggressive follicle centre lymphomas, is restricted to the B-lymphoid cell lineage: A study by FISH in combination with morphology and immunocytochemistry

British Journal of Haematology

Volumn 105, Issue 4, 1999, Pages 1140-1144

  Bernell, P ^a   Arvidsson, I ^a   Jacobsson, B ^a  

^a DANDERYD HOSPITAL   (Sweden)

Author keywords

Chromosome 7; FISH; High grade B cell lymphomas; Immunocytochemistry; Morphology

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN;

ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CHROMOSOME 7; CLINICAL ARTICLE; DIAGNOSTIC VALUE; DISEASE COURSE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOTHERAPY; PRIORITY JOURNAL;

BONE MARROW DISEASES; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 7; DISEASE PROGRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHATIC METASTASIS; LYMPHOMA, B-CELL;

EID: 0033032428     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01526.x     Document Type: Article

References (13)

1. Bernell, P., Arvidsson, I., Jacobsson, B. & Hast, R. (1996a) Fluorescence in situ hybridization in combination with morphology detects minimal residual disease and heralds relapse in acute leukaemia. British Journal of Haematology 95, 666-672.
2. Bernell, P., Arvidsson, I., Jacobsson, B., Stenke, L. & Hast, R. (1997) Differences in cell lineage involvement between de novo AML and MDS-AML studied by fluorescence in situ hybridization and morphology. European Journal of Haematology 58, 241-245.
3. Bernell, P., Jacobsson, B., Liliemark, J., Arvidsson, I. & Hast, R. (1998) Gain of chromosome 7 marks the progression from indolent to aggressive follicle centre lymphoma and is a common finding in patients with diffuse large B-cell lymphoma: a study by FISH. British Journal of Haematology, 101, 487-491.
4. Bernell, P., Jacobsson, B., Nordgren, A. & Hast, R. (1996b) Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology. Leukemia, 10, 662-668.
5. Fialkow, P.J., Singer, J.W., Adamson, J.M., Vaidya, K., Dow, L.W. & Ochs, J. (1981) Acute non-lymphocytic leukemia: heterogeneity of stem cell origin. Blood, 57, 1068-1073.
6. Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K.C., Cleary, M.L., Delsol, G., De Wolf-Peeters, C., Falini, B., Gatter, K.C., Grogan, T.M., Isaacson, P.G., Knowles, D.M., Mason, D.Y., Muller-Hermelink, H.K., Pilero, S.A., Piris, M.A., Ralfkiaer, E. & Warnke, R.A. (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood, 84, 1361-1392.
7. Jacobsson, B., Bernell, P., Arvidsson, I. & Hast, B. (1996) Classical morphology, esterase cytochemistry and interphase cytogenetics of peripheral blood and bone marrow smears. Journal of Histochemistry and Cytochemistry 44, 1303-1309.
8. Johansson, B., Meretens, F. & Mitelman, F. (1995) Cytogenetic evolution patterns in non-Hodgkin's lymphoma. Blood, 86, 3905-3914.
9. Keinänen, M., Griffin, J.D., Bloomfield, C.D., Machnicki, J. & De La Chapelle, A. (1988) Clonal chromosomal abnormalities showing multiple-cell lineage involvement in acute myeloid leukemia. New England Journal of Medicine, 318, 1153-1158.
10. Kibbelaar, R.E., van Kamp, H., Dreef, E.J., de Groot-Swings, G., Kluin-Nelemans, J.C. & Beverstock, G.C. (1992) Combined immunophenotyping and DNA in situ hybridization to study lineage involvement in patients with myelodysplastic syndromes. Blood, 79, 1823-1828.
11. Knuutila, S., Tecrenhovi, L., Larramendy, M.L., Elonen, E., Franssila, K.O., Nylund, S.J., Timonen, T., Heinonen, K., Mahlamäki, E., Winqvist, R. & Ruutu, T. (1994) Cell lineage involvement of recurrent chromosomal abnormalities in hematologic neoplasms. Genes. Chromosomes and Cancer, 10, 95-102.
12. Offit, K., Jhanwar, S.C., Ladanyi, M., Filippa, D.A. & Chaganti, R.S.K. (1991) Cytogenetic analysis of 434 consecutively ascertained specimens or non-Hodgkin's lymphoma: correlations between recurrent aberrations, histology and exposure of cytotoxic treatment. Genes, Chromosomes and Cancer, 1, 189-201.
13. Van Lom, K., Hagemeijer, A., Smit, E.M.E. & Löwenberg, B. (1993) In situ Hybridization on May-Grünwald-Giemsa-stained bone marrow and blood smears of patients with hematologic disorders allow detection of cell lineage-specific cytogenetic abnormalities. Blood, 82, 884-888.